(p < 0, 001) for Trudexa/ methotrexat- kombinationsterapi end for methotrexat- monoterapi og Trudexa - monoterapi efter 52 uger.
showed greater improvement (p < 0.001) for Trudexa/ methotrexate combination therapy versus methotrexate monotherapy and Trudexa monotherapy at week 52, which was maintained through week 104.